Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Freerk van Dijk

Freerk van Dijk

Bioinformaticus

Kuiper groep

Telefoon 088 97 27 682

E-mail F.vanDijk-5@prinsesmaximacentrum.nl

Comparison of clinical selection-based genetic testing with phenotype-agnostic extensive germline sequencing to diagnose genetic predisposition in children with cancer
- aug. 2024
- Jette J, Bakhuizen, et al
- The Lancet. Child & adolescent health
A novel germline PAX5 single exon deletion in a pediatric patient with precursor B-cell leukemia
- jan. 2023
- N, van Engelen, et al
- Leukemia
Implementation of paediatric precision oncology into clinical practice
- nov. 2022
- Karin P.S., Langenberg, et al
- European Journal of Cancer
Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort
- jun. 2022
- Janna A, Hol, et al
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
- feb. 2022
- , et al
- Science Translational Medicine

Bekijk alle publicaties

Freerk van Dijk

Publicaties

Comparison of clinical selection-based genetic testing with phenotype-agnostic extensive germline sequencing to diagnose genetic predisposition in children with cancer

A novel germline PAX5 single exon deletion in a pediatric patient with precursor B-cell leukemia

Implementation of paediatric precision oncology into clinical practice

Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS